[Federal Register: June 1, 1999 (Volume 64, Number 104)] [Notices] [Page 29328-29329] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr01jn99-74] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Genetics of Drug Abuse Vulnerability. Date: June 1-2, 1999. Time: 9:00 AM to 5:00 PM. Agenda: To review and evaluate grant applications. Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes Street, Arlington, VA 22202. Contact Person: Rita Liu, PHD, Health Scientist Administrator, Office of Extramural Program Review, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443- 2620. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, National Drug Abuse Treatment Clinical Trials Network. Date: June 22-23, 1999. Time: 9:00 AM to 5:00 PM. Agenda: To review and evaluate grant applications. Place: Omni Shoreham Hotel, 2500 Calvert Street, NW., Washington, DC 20008. Contact Person: Susan L. Coyle, PHD, Chief, Clinical Epidemiological and Applied Sciences Review Branch, Office of Extramural Program Review, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Program Projects Review Committee. Date: June 29, 1999. Time: 8:30 AM to 5:00 PM. Agenda: To review and evaluate grant applications. Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA 22209. Contact Person: Rita Liu, PHD, Health Scientist Administrator, Office of Extramural Program Review, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443- 2620. Name of Committee: National Institute on Drug Abuse Initial Review Group Treatment Research Subcommittee. Date: June 29-30, 1999. Time: 9:00 AM to 5:00 PM. Agenda: To review and evaluate grant applications. Place: Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878. Contact Person: Kesinee Nimit, MD, Health Scientist Administrator, Office of Extramural Program Review, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1432. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Centers Review Committee. Date: June 30, 1999. Time: 8:30 AM to 5:00 PM. Agenda: To review and evaluate grant applications. Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA 22209. Contact Person: Rita Liu, PHD, Health Scientist Administrator, Office of Extramural Program Review, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443- 2620. Name of Committee: National Institute on Drug Abuse Initial Review Group Training and Career Development Subcommittee. Date: July 7-9, 1999. Time: 9:00 AM to 5:00 PM. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda One, Bethesda Metro Center Bethesda, MD 20814. Contact Person: Mark Swieter, PHD, Health Scientist Administrator, Office of Extramural Program Review, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547 (301) 435-1389. Name of Committee: National Institute on Drug Abuse Initial Review Group Health Services Research Subcommittee. [[Page 29329]] Date: July 14, 1999. Time: 9:00 AM to 5:00 PM. Agenda: To review and evaluate grant applications. Place: Omni Shoreham Hotel, 2500 Calvert Street, NW, Washington, DC 20008. Contact Person: Marina L. Volkov, PHD, Special Assistant, Office of Extramural Program Review, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547 (301) 435-1433. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Research on Drug Courts. Date: July 19-20, 1999. Time: 9:00 AM to 5:00 PM. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Hotel, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Marina L. Volkov, PHD, Special Assistant, Office of Extramural Program Review, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1433. (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse Research Programs, National Institutes of Health, HHS) Dated: May 23, 1999. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy, NIH. [FR Doc. 99-13751 Filed 5-28-99; 8:45 am] BILLING CODE 4140-01-M